Amy Horton is CAO & VP at CRYOLIFE INC (CRY). They have made 43 open-market trades across 2 companies since 2007, most recently 2026-03-03.
CIK 0001371523
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 43 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AORT | 139,088 | $3.0M |
| CRY | 86,782 | $1.3M |
| Total | $4.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AORT | SELL | 2026-03-03 | 2026-03-04 | $37.78 | $34K | -2.0% | -12.2% | -46.4% |
| AORT | SELL | 2026-03-02 | 2026-03-03 | $38.02 | $24K | -5.9% | -11.7% | -45.6% |
| AORT | SELL | 2026-02-23 | 2026-02-25 | $36.97 | $95K | +1.7% | -0.9% | -34.6% |
| AORT | SELL | 2025-12-08 | 2025-12-09 | $44.42 | $406K | +7.1% | +3.2% | -17.0% |
| AORT | SELL | 2025-11-17 | 2025-11-18 | $45.73 | $274K | +2.1% | +5.0% | -18.7% |
| AORT | SELL | 2025-11-13 | 2025-11-14 | $45.86 | $319K | +3.0% | +0.4% | -10.0% |
| AORT | SELL | 2025-11-10 | 2025-11-12 | $44.62 | $160K | -3.2% | -4.6% | -14.7% |
| AORT | SELL · 10b5-1 | 2025-08-08 | 2025-08-11 | $38.49 | $615K | +0.6% | -4.3% | +4.8% |
| AORT | SELL | 2025-03-06 | 2025-03-10 | $24.80 | $26K | +3.4% | +2.4% | +24.7% |
| AORT | SELL | 2025-02-24 | 2025-02-26 | $27.31 | $91K | -7.0% | -4.0% | +15.6% |
| AORT | SELL | 2024-12-06 | 2024-12-09 | $29.66 | $128K | -2.8% | +5.0% | -18.4% |
| AORT | SELL | 2024-12-06 | 2024-12-10 | $29.05 | $257K | -4.6% | +0.1% | -21.3% |
| AORT | SELL · 10b5-1 | 2024-10-01 | 2024-10-02 | $26.18 | $651K | -0.3% | +1.8% | +8.8% |
| AORT | SELL | 2024-03-05 | 2024-03-14 | $18.72 | $22K | +2.8% | +1.9% | +18.0% |
| AORT | SELL | 2024-02-27 | 2024-03-14 | $19.83 | $6K | +2.8% | +1.9% | +18.0% |
| AORT | SELL | 2024-02-26 | 2024-02-28 | $20.27 | $44K | +4.4% | +11.1% | +22.9% |
| AORT | SELL | 2024-02-26 | 2024-03-14 | $20.27 | $43K | +2.8% | +1.9% | +18.0% |
| AORT | SELL | 2024-02-20 | 2024-02-22 | $18.87 | $32K | -5.6% | +1.7% | +20.7% |
| AORT | SELL · 10b5-1 | 2023-12-15 | 2023-12-19 | $19.00 | $274K | -2.4% | -2.4% | +8.1% |
| AORT | SELL | 2023-11-27 | 2023-11-29 | $17.34 | $36K | +1.6% | +0.7% | +10.4% |
| AORT | SELL | 2023-03-02 | 2023-03-03 | $13.41 | $9K | -11.3% | -6.5% | +8.0% |
| AORT | SELL | 2023-02-27 | 2023-03-01 | $12.94 | $18K | -7.7% | +2.2% | +16.1% |
| AORT | SELL | 2023-02-17 | 2023-02-21 | $14.09 | $254K | +3.4% | -11.1% | +14.0% |
| AORT | SELL | 2022-12-14 | 2022-12-16 | $13.57 | $44K | -3.2% | +2.7% | -1.6% |
| CRY | SELL | 2021-12-08 | 2021-12-10 | $18.57 | $46K | +8.4% | +10.6% | +39.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.